Genomic Testing Market Projected to Reach US$ 41.34 Billion by 2035, Supported by Rising Clinical Oncology Testing Volumes | Astute Analytica

The market is rapidly transitioning from episodic diagnostics to continuous health monitoring. By 2035, the integration of ...

Decoy Therapeutics Reaches Global Access Commitment Agreement to Focus on Development of a Globally Accessible, Scalable Peptide-Conjugate Manufacturing Platform

Decoy Therapeutics, Inc. (Nasdaq: DCOY) (Decoy, or the Company), a preclinical biopharmaceutical that is engineering the next generation of peptide conjugate therapeutics, announces that the ...